Trump looks to end $56 million grant to give Narcan to first responders to help save lives during an overdose
The Trump administration is looking at plans to end a $56 million annual grant program that distributes the overdose-countering medication Narcan to first responders across the country, according to a draft proposal.
A preliminary budget document, obtained by The Washington Post, reportedly calls for deep cuts to federal health programs and targets multiple addiction prevention and treatment programs, including training of community responders to administer Narcan.
Narcan – known generically as naloxone – is a nasal spray that works to reverse the effects of an opioid overdose in two to three minutes. It is widely used to combat overdoses from serious drugs, including fentanyl.
Though state and local governments have alternative resources than federal programs to obtain Narcan, experts are concerned that the axing of the grant may send a message about the government's view on such training.
'Reducing the funding for naloxone and overdose prevention sends the message that we would rather people who use drugs die than get the support they need and deserve,' Dr Melody Glenn, an addiction medicine physician and assistant professor at the University of Arizona, told The New York Times.
The grants were awarded through the Substance Abuse and Mental Health Services Administration, an agency within the Department of Health and Human Services. The administration would be eliminated under the draft budget proposal, per the Post
'Narcan has been kind of a godsend as far as opioid epidemics are concerned, and we certainly are in the middle of one now with fentanyl,' Donald McNamara of the Los Angeles County Sheriff's Department told The Times. 'We need this funding source because it's saving lives every day.'
According to the Substance Abuse and Mental Health Services Administration, 66,000 police officers, firefighters and other emergency responders were trained in 2024 using the grant money. Over 282,500 Narcan kits were distributed.
The proposal to cut the program and other treatment programs comes in somewhat surprising contrast to the views of newly instated health secretary, Robert F. Kennedy Jr., who has been vocal in his desire to address America's drug crisis.
Last year, during his independent presidential campaign, Kennedy, who has spoken publicly of his own heroin addiction, produced a documentary that outlined addiction support with federal backing.
The Independent has requested comment from the White House and the Department of Health and Human Services about reports that the grant will be cut.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
3 hours ago
Federal judge rules Tump directives canceling NIH grants are 'void,' 'illegal'
A federal judge in Massachusetts ruled on Monday that directives from the Trump administration that led to the cancellations of several research grants from the National Institutes of Health (NIH) were "void" and "illegal." U.S. District Judge William Young said the cancellation of the grants -- related to studies involving LGBTQ+ issues, gender identity and diversity, equity and inclusion (DEI) -- violated federal law, saying it was a case of racial discrimination and discrimination against the LGBTQ+ community, according to the plaintiffs in the case. Two lawsuits had been filed against the administration: One led by the American Public Health Association and the other filed by a group of 16 states. Some estimates have suggested that up to $1.8 billion in research funding had been cut. Young, an appointee of President Ronald Reagan, said he was ordering the NIH to restore the grants that were terminated. In a statement, Andrew Nixon, the director of communications for the Department of Health and Human Services, said the agency stands by its decision to end funding for research "that prioritized ideological agendas over scientific rigor and meaningful outcomes for the American people. Under the leadership of Secretary Kennedy and the Trump administration, HHS is committed to ensuring that taxpayer dollars support programs rooted in evidence-based practices and gold standard science – not driven by divisive DEI mandates or gender ideology." Nixon said HHS is "exploring all legal options, including filing an appeal and moving to stay the order." Among the plaintiffs is Dr. Brittany Charlton, an associate professor at Harvard T.H. Chan School of Public Health, who had all her grants terminated by the NIH. One of the terminated grants focused on documenting obstetrical outcomes for lesbian, gay and bisexual women and another focused on how discriminatory laws impact mental health among LGBTQ+ teens. "As a plaintiff, I felt truly seen -- it was a rare moment when the deep harm caused to researchers and the communities we serve was acknowledged out loud, in front of the world," Charlton told ABC News in a statement. "Sitting there, I felt a wave of relief and hope as the judge condemned the government's actions and ordered the grants to be reinstated," the statement continued. "After so much uncertainty and disruption, it finally felt like justice and the value of our research -- and the communities at its heart -- were being affirmed." The terminations came after President Donald Trump passed a flurry of executive orders including vowing to " defend women from gender ideology extremism" and aiming to dismantle DEI initiatives. According to termination letters sent to researchers at various universities that were reviewed by ABC News, the administration said the canceled projects do not serve the "priorities" of the current administration. "Research programs based on gender identity are often unscientific, have little identifiable return on investment, and do nothing to enhance the health of many Americans. Many such studies ignore, rather than seriously examine, biological realities. It is the policy of NIH not to prioritize these research programs," some of the termination letters read. "The premise…is incompatible with agency priorities, and no modification of the project could align the project with agency priorities," the letters continued.
Business Insider
4 hours ago
- Business Insider
Senate Republicans abandon Medicare cost cuts, Bloomberg reports
Senate Republicans are proposing cuts to Medicaid for low-income and disabled people that are more aggressive than policies the House passed to help pay for President Trump's tax package, Rachel Cohrs Zhang of Bloomberg reports, citing people familiar with the legislation. Senate Republicans, however, abandoned efforts to cut costs in Medicare, which is good news for Humana (HUM) and UnitedHealth (UNH), which are major players in the Medicare Advantage insurance market, according to Bloomberg. The Senate plan, to be be released on Monday, solidifies Republicans' decision to cut funding for Medicaid health insurance for the poor to pay for tax cuts, Bloomberg adds. Publicly traded companies in the space health insurance space include CVS Health (CVS), Centene (CNC), Cigna (CI), Elevance Health (ELV), Humana (HUM), Molina Healthcare (MOH) and UnitedHealth (UNH). Confident Investing Starts Here:
Los Angeles Times
7 hours ago
- Los Angeles Times
Judge rules some NIH grant cuts illegal, saying he's never seen such discrimination in 40 years
WASHINGTON — A federal judge ruled Monday it was illegal for the Trump administration to cancel several hundred research grants, adding that the cuts raise serious questions about racial discrimination. U.S. District Judge William Young in Massachusetts said the administration's process was 'arbitrary and capricious' and that it did not follow long-held government rules and standards when it abruptly canceled grants deemed to focus on gender identity or diversity, equity and inclusion. In a hearing Monday on two cases calling for the grants to be restored, the judge pushed government lawyers to offer a formal definition of DEI, questioning how grants could be canceled for that reason when some were designed to study health disparities as Congress had directed. Young, an appointee of Republican President Ronald Reagan, went on to address what he called 'a darker aspect' to the cases, calling it 'palpably clear' that what was behind the government actions was 'racial discrimination and discrimination against America's LGBTQ community.' After 40 years on the bench, 'I've never seen government racial discrimination like this,' Young added. He ended Monday's hearing saying, 'Have we no shame.' During his remarks ending the hearing, the judge said he would issue his written order soon. Young's decision addresses only a fraction of the hundreds of NIH research projects the Trump administration has cut — those specifically addressed in two lawsuits filed separately this spring by 16 attorneys general from Democratic states, public health advocacy groups and some affected scientists. A full count wasn't immediately available. In the California lawsuit, filed in April with the other Democratic states, Atty. Gen. Rob Bonta said the UC system had received more than $2 billion in NIH awards in 2024 and that CSU had spent more than $90 million on NIH-funded research the same year. At the time of filing, Bonta wrote that the UC system's five health centers were awaiting action on grant proposals totaling $563 million. While Young said the funding must be restored, Monday's action was an interim step as the ruling could be appealed. The Trump administration is 'exploring all legal options' including asking the judge to stay the ruling or appealing, said Andrew Nixon, a spokesman for NIH's parent agency, the Department of Health and Human Services. 'HHS stands by its decision to end funding for research that prioritized ideological agendas over scientific rigor and meaningful outcomes for the American people,' he said in an email. While the original lawsuits didn't specifically claim racial discrimination, they said the new NIH policies prohibited 'research into certain politically disfavored subjects.' In a filing this month after the lawsuits were consolidated, lawyers said the NIH did not highlight genuine concerns with the hundreds of canceled research projects studies, but instead sent 'boilerplate termination letters' to universities. The topics of research ranged widely, including cardiovascular health, sexually transmitted infections, depression, Alzheimer's and alcohol abuse in minors, among other things. Attorneys cited projects such as one tracking how medicines may work differently in people of ancestrally diverse backgrounds, and said the cuts affected more than scientists — such as potential harm to patients in a closed study of suicide treatment. Lawyers for the federal government said in a court filing earlier this month that NIH grant terminations for DEI studies were 'sufficiently reasoned,' adding later that 'plaintiffs may disagree with NIH's basis, but that does not make the basis arbitrary and capricious.' The NIH, lawyers argued, has 'broad discretion' to decide on and provide grants 'in alignment with its priorities' — which includes ending grants. Monday, Justice Department lawyer Thomas Ports Jr. pointed to 13 examples of grants related to minority health that NIH either hadn't cut or had renewed in the same time period — and said some of the cancellations were justified by the agency's judgement that the research wasn't scientifically valuable. The NIH has long been the world's largest public funder of biomedical research. Neergaard writes for the Associated Press. Times staff writer Jaweed Kaleem contributed to this story.
